Dosing of Gd-DTPA in MR imaging of intracranial tumors
- 1 December 1991
- journal article
- clinical trial
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 22 (2) , 249-254
- https://doi.org/10.1002/mrm.1910220218
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Is Gd-DTPA required for routine cranial MR imaging?Radiology, 1989
- Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brainNeuroradiology, 1988
- Benefits of Gd-DTPA for MR Imaging of Intracranial AbnormalitiesJournal of Computer Assisted Tomography, 1988
- Brain tumors: MR imaging with gadolinium-DTPA.Radiology, 1985
- A strategy for magnetic resonance imaging of the head: results of a semi-empirical model. Part II.Radiology, 1984
- INTRAVENOUS CHELATED GADOLINIUM AS A CONTRAST AGENT IN NMR IMAGING OF CEREBRAL TUMOURSThe Lancet, 1984
- Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review.Radiology, 1983